医药健康业
Search documents
“专精特新”专板三年汇聚1.56万家企业
Zheng Quan Ri Bao· 2025-11-17 23:23
本报记者 吴晓璐 毛艺融 2022年11月18日,中国证监会办公厅、工业和信息化部办公厅联合发布了《关于高质量建设区域性 股权市场"专精特新"专板的指导意见》(以下简称《指导意见》)。三年来,三批共计26家区域性股权 市场"专精特新"专板(以下简称"专板")完成备案。权威数据显示,截至今年9月底,26家专板共服务 企业1.56万家,其中,国家级专精特新"小巨人"企业1298家,专精特新中小企业9197家,上市后备企业 1098家。 三年筑基,育树成林,专板已成为各地汇聚专精特新中小企业的"苗圃",精准赋能入板企业,在助 力融资、培育上市等方面发挥了积极作用,资本市场"塔基"功能有效发挥,为加速培育新质生产力注入 了强劲动力。 集聚效应凸显 产业布局高度契合新质生产力 在区域性股权市场完成专板建设方案备案后,江苏、天津、河北、河南等多地出台了支持专板发展 的具体举措,引导符合条件的企业在专板挂牌融资,为入板企业推出专项服务,助力高标准建设专板。 目前,入板企业多集中于战略性新兴产业和未来产业,与培育新质生产力的方向高度契合,形成了 良好的示范效应。 例如,北京"专精特新"专板是全国首批备案的专板之一。北京股权交 ...
“苗圃”“塔基”功能彰显 “专精特新”专板三年汇聚1.56万家企业
Zheng Quan Ri Bao· 2025-11-17 16:05
本报记者 吴晓璐 毛艺融 2022年11月18日,中国证监会办公厅、工业和信息化部办公厅联合发布了《关于高质量建设区域性股权市场"专精特新"专 板的指导意见》(以下简称《指导意见》)。三年来,三批共计26家区域性股权市场"专精特新"专板(以下简称"专板")完成 备案。权威数据显示,截至今年9月底,26家专板共服务企业1.56万家,其中,国家级专精特新"小巨人"企业1298家,专精特新 中小企业9197家,上市后备企业1098家。 三年筑基,育树成林,专板已成为各地汇聚专精特新中小企业的"苗圃",精准赋能入板企业,在助力融资、培育上市等方 面发挥了积极作用,资本市场"塔基"功能有效发挥,为加速培育新质生产力注入了强劲动力。 集聚效应凸显 产业布局高度契合新质生产力 在区域性股权市场完成专板建设方案备案后,江苏、天津、河北、河南等多地出台了支持专板发展的具体举措,引导符合 条件的企业在专板挂牌融资,为入板企业推出专项服务,助力高标准建设专板。 目前,入板企业多集中于战略性新兴产业和未来产业,与培育新质生产力的方向高度契合,形成了良好的示范效应。 例如,北京"专精特新"专板是全国首批备案的专板之一。北京股权交易中心 ...
北京“专精特新”专板开板两周年,AI等前沿领域企业占比近九成
Xin Jing Bao· 2025-08-27 07:02
Core Insights - Beijing's "Specialized, Refined, Characteristic, and Innovative" board has been operational for two years, with 809 companies listed and total financing exceeding 22 billion yuan [1][2] - The majority of companies on the board are in cutting-edge fields such as new generation information technology, software and information services, artificial intelligence, biomedicine, intelligent manufacturing, and new energy materials, accounting for nearly 90% [1] Company Performance - Among the 809 companies, 160 are innovative small and medium-sized enterprises (SMEs), representing 19.78%; 471 are city-level specialized SMEs, accounting for 58.22%; and 129 are national-level "little giant" enterprises, making up 15.95% [1] - In terms of financial performance, 179 companies have revenue exceeding 100 million yuan, which is 22.13% of the total; nearly half of the companies have revenue over 30 million yuan [1] - Regarding innovation, 195 companies have R&D expenditures exceeding 20 million yuan, representing 24.10%; 351 companies have R&D expenditures over 10 million yuan, accounting for 43.39% [1] Industry Distribution - The industry distribution of the companies on the board reflects Beijing's high-precision and cutting-edge industry types, with the information industry comprising 42.03% (340 companies); the pharmaceutical and health industry follows at 16.44% (133 companies); advanced manufacturing and intelligent equipment account for 10.26% (83 companies); artificial intelligence and new materials have 82 and 44 companies, respectively [2] - The distribution of industries aligns with the unique attributes of Beijing's ten high-precision and cutting-edge industries, showcasing the characteristics of "specialized, refined, characteristic, and innovative" enterprises [2] Policy and Support - To enhance the multi-level capital market's role in supporting SMEs, the "Guiding Opinions on High-Quality Construction of Regional Equity Market 'Specialized, Refined, Characteristic, and Innovative' Board" was issued in November 2022 [2] - The Beijing Municipal Bureau of Economy and Information Technology, along with other financial regulatory bodies, developed the "Beijing 'Specialized, Refined, Characteristic, and Innovative' Board Construction Plan," which was approved by the China Securities Regulatory Commission on June 30, 2023, establishing the first "Specialized, Refined, Characteristic, and Innovative" board in the country [2]